Gerard L, Delourme M, Tardy C, Ganne B, Perrin P, Chaix C
Eur J Hum Genet. 2024; .
PMID: 39725690
DOI: 10.1038/s41431-024-01781-x.
Arends T, Hamm D, van der Maarel S, Tapscott S
Cold Spring Harb Perspect Biol. 2024; .
PMID: 39009417
PMC: 11733064.
DOI: 10.1101/cshperspect.a041492.
Wong M, Hachmer S, Gardner E, Runfola V, Arezza E, Megeney L
Nucleic Acids Res. 2024; 52(16):9450-9462.
PMID: 38994563
PMC: 11381350.
DOI: 10.1093/nar/gkae600.
Shim Y, Seo J, Lee S, Choi J, Choi Y, Shin S
Ann Lab Med. 2024; 44(5):437-445.
PMID: 38724225
PMC: 11169776.
DOI: 10.3343/alm.2023.0437.
Ma Y, Schwager Karpukhina A, Dib C, Gautier C, Hermine O, Allemand E
Sci Adv. 2024; 10(18):eadl1922.
PMID: 38691604
PMC: 11062572.
DOI: 10.1126/sciadv.adl1922.
Best practice guidelines on genetic diagnostics of facioscapulohumeral muscular dystrophy: Update of the 2012 guidelines.
Giardina E, Camano P, Burton-Jones S, Ravenscroft G, Henning F, Magdinier F
Clin Genet. 2024; 106(1):13-26.
PMID: 38685133
PMC: 11147721.
DOI: 10.1111/cge.14533.
Molecular mechanisms and therapeutic strategies for neuromuscular diseases.
Zambon A, Falzone Y, Bolino A, Previtali S
Cell Mol Life Sci. 2024; 81(1):198.
PMID: 38678519
PMC: 11056344.
DOI: 10.1007/s00018-024-05229-9.
Voluntary wheel running improves molecular and functional deficits in a murine model of facioscapulohumeral muscular dystrophy.
Bittel A, Bittel D, Gordish-Dressman H, Chen Y
iScience. 2024; 27(1):108632.
PMID: 38188524
PMC: 10770537.
DOI: 10.1016/j.isci.2023.108632.
Flavones provide resistance to DUX4-induced toxicity via an mTor-independent mechanism.
Cohen J, Huang S, Koczwara K, Woods K, Ho V, Woodman K
Cell Death Dis. 2023; 14(11):749.
PMID: 37973788
PMC: 10654915.
DOI: 10.1038/s41419-023-06257-2.
Autosomal dominant in cis D4Z4 repeat array duplication alleles in facioscapulohumeral dystrophy.
Lemmers R, Butterfield R, van der Vliet P, De Bleecker J, van der Pol L, Dunn D
Brain. 2023; 147(2):414-426.
PMID: 37703328
PMC: 10834250.
DOI: 10.1093/brain/awad312.
Molecular and Phenotypic Changes in FLExDUX4 Mice.
Murphy K, Zhang A, Bittel A, Chen Y
J Pers Med. 2023; 13(7).
PMID: 37511653
PMC: 10381554.
DOI: 10.3390/jpm13071040.
SMCHD1 and LRIF1 converge at the FSHD-associated D4Z4 repeat and LRIF1 promoter yet display different modes of action.
Sikrova D, Testa A, Willemsen I, van den Heuvel A, Tapscott S, Daxinger L
Commun Biol. 2023; 6(1):677.
PMID: 37380887
PMC: 10307901.
DOI: 10.1038/s42003-023-05053-0.
Complex 4q35 and 10q26 Rearrangements: A Challenge for Molecular Diagnosis of Patients With Facioscapulohumeral Dystrophy.
Delourme M, Charlene C, Gerard L, Ganne B, Perrin P, Vovan C
Neurol Genet. 2023; 9(3):e200076.
PMID: 37200893
PMC: 10188231.
DOI: 10.1212/NXG.0000000000200076.
Facioscapulohumeral muscular dystrophy: the road to targeted therapies.
Tihaya M, Mul K, Balog J, de Greef J, Tapscott S, Tawil R
Nat Rev Neurol. 2023; 19(2):91-108.
PMID: 36627512
PMC: 11578282.
DOI: 10.1038/s41582-022-00762-2.
Knocking Down DUX4 in Immortalized Facioscapulohumeral Muscular Dystrophy Patient-Derived Muscle Cells.
Lim K, Yokota T
Methods Mol Biol. 2022; 2587:197-208.
PMID: 36401032
DOI: 10.1007/978-1-0716-2772-3_12.
Simultaneous measurement of the size and methylation of chromosome 4qA-D4Z4 repeats in facioscapulohumeral muscular dystrophy by long-read sequencing.
Hiramuki Y, Kure Y, Saito Y, Ogawa M, Ishikawa K, Mori-Yoshimura M
J Transl Med. 2022; 20(1):517.
PMID: 36348371
PMC: 9644496.
DOI: 10.1186/s12967-022-03743-7.
Gastrointestinal cancer occurs as extramuscular manifestation in FSHD1 patients.
Kurashige T, Morino H, Ueno H, Murao T, Watanabe T, Hinoi T
J Hum Genet. 2022; 68(2):91-95.
PMID: 36336708
PMC: 9873551.
DOI: 10.1038/s10038-022-01095-0.
Transplantation of PSC-derived myogenic progenitors counteracts disease phenotypes in FSHD mice.
Azzag K, Bosnakovski D, Tungtur S, Salama P, Kyba M, Perlingeiro R
NPJ Regen Med. 2022; 7(1):43.
PMID: 36056021
PMC: 9440030.
DOI: 10.1038/s41536-022-00249-0.
Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy.
Mariot V, Dumonceaux J
Front Genome Ed. 2022; 4:937879.
PMID: 35910413
PMC: 9334676.
DOI: 10.3389/fgeed.2022.937879.
FSHD Therapeutic Strategies: What Will It Take to Get to Clinic?.
Himeda C, Jones P
J Pers Med. 2022; 12(6).
PMID: 35743650
PMC: 9225474.
DOI: 10.3390/jpm12060865.